共 50 条
Implantable Devices and Magnetic Resonance Imaging
被引:7
|作者:
Hsu, Chijen
[1
,3
]
Parker, Geoffrey
[2
,3
]
Puranik, Rajesh
[1
,3
]
机构:
[1] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW 2050, Australia
[2] Royal Prince Alfred Hosp, Dept Radiol, Sydney, NSW 2050, Australia
[3] Royal Prince Alfred Hosp, Med Ctr, Sydney, NSW 2050, Australia
来源:
关键词:
Magnetic resonance imaging;
Pacemaker;
Implantable-cardioverter-defibrillator;
CARDIOVERTER-DEFIBRILLATORS;
CARDIAC-PACEMAKERS;
PERMANENT PACEMAKERS;
1.5;
TESLA;
IN-VIVO;
ELECTRONIC DEVICES;
SAFE PERFORMANCE;
MRI;
PROTOCOL;
PERSPECTIVE;
D O I:
10.1016/j.hlc.2012.04.004
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The indications for cardiovascular implantable electronic devices (CIEDs) are ever expanding, seemingly in parallel to the similar widespread increase in the use of magnetic resonance imaging (MRI), where there are clear advantages of imaging with no ionizing radiation and superior tissue contrast. However, CIEDs have traditionally been considered an absolute contraindication to MRI, posing a major limitation to investigating various pathologies after implantation of such devices. In the last decade the traditional paradigm of avoiding MRI in patients with CIEDs has been challenged with studies demonstrating relative safety at 1.5 T under certain circumstances. Now with the recent approval of 'MR conditional' devices, it is becoming increasingly apparent that CIEDs should no longer be considered an absolute contraindication to MRI. (Heart, Lung and Circulation 2012;21:358-363) Crown Copyright (C) 2012 Published by Elsevier Inc. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.
引用
收藏
页码:358 / 363
页数:6
相关论文